The Therapeutic Goods Administration (TGA), Australia’s medicines regulator, has sought more information from Pfizer after a respected medical journal alleged serious problems with its vaccine safety trials in the United States.
The British Medical Journal’s report published on Nov. 2 is based on the allegations of a former employee of Texas-based Ventavia Research Group, a contractor involved in Pfizer’s phase III trial for COVID vaccine in 2020.
